| Oct 8 |
Nyxoah Secures $27 Million to Boost U.S. Presence
|
| Oct 7 |
Nyxoah raises $27M through its at-the-market offering
|
| Oct 7 |
Nyxoah Raises $27 Million through its At-the-Market Offering
|
| Sep 27 |
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
|
| Sep 27 |
Publication relating to transparency notifications
|
| Sep 2 |
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
|
| Aug 11 |
Nyxoah S.A. (NYXH) Q2 2024 Earnings Call Transcript
|
| Aug 6 |
Nyxoah SA (NYXH) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 6 |
Nyxoah GAAP EPS of -€0.43, revenue of €0.77M
|
| Aug 6 |
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
|
